EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing

Miruna Gug, Adrian Rațiu, Nicoleta Andreescu iD, Simona Farcaș, Sorina Laitin, Cristina Gug

Journal of Personalized Medicine · 29.03.2024 · 14 (4) · 366

DOI: 10.3390/jpm14040366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 29.03.2024. Verfasst von Miruna Gug und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study represents our second investigation into NIPT, involving a more extensive patient cohort with a specific emphasis on the high-risk group. The high-risk group was subsequently divided into two further groups to compare confirmed cases versus unconfirmed via direct methods. The methodology encompassed the analysis of 1400 consecutive cases from a single genetic center in western Romania, where NIPT was used to assess the risk of specific fetal chromosomal abnormalities. All high-risk cases underwent validation through direct analysis of fetal cells obtained via invasive methods, including chorionic villus sampling and amniocentesis. The confirmation process utilized QF-PCR, karyotyping, and SNP-Array methods customized to each case. Results: A high risk of aneuploidy at NIPT was identified in 36 out of 1400 (2.57%) cases and confirmed in 28 cases. The study also detected an increased risk for copy number variations (CNVs) in 1% of cases, confirmed in two instances involving one large microdeletion and one large microduplication. Trisomy 21 was the exclusive anomaly where NIPT confirmed all cases with identified risk. High-risk NIPT results which were not validated by invasive methods, were classified as false positives; parents in these cases determined to continue the pregnancy. In conclusion, NIPT can serve as a screening method for all pregnancies; however, in high-risk cases, an invasive confirmation test is strongly recommended.

Schlagwörter

Stichwörter der Autor:innen

CNVscffDNAfetal aneuploidynon-invasive prenatal testingprenatal diagnostics

Autor:innen und Institutionen

  • Doctoral School, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Medical Genetics Office Dr. Gug, 300200 Timisoara, Romania.
  • Department of Obstetrics and Gynecology II, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Timisoara Municipal Emergency Clinical Hospital, 300202 Timisoara, Romania.
  • Department of Microscopic Morphology, Discipline of Genetics, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Genomic Medicine Centre, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

ORCID-Profile: Nicoleta Andreescu

Zitieren

APA

Gug, M., Rațiu, A., Andreescu, N., Farcaș, S., Laitin, S., & Gug, C. (2024). Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing. Journal of Personalized Medicine, 14(4), 366. https://doi.org/10.3390/jpm14040366

Vancouver

Gug M, Rațiu A, Andreescu N, Farcaș S, Laitin S, Gug C. Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing. Journal of Personalized Medicine. 2024;14(4):366. doi:10.3390/jpm14040366

BibTeX
@article{Gug2024,
  author = {Gug, Miruna and Rațiu, Adrian and Andreescu, Nicoleta and Farcaș, Simona and Laitin, Sorina and Gug, Cristina},
  title = {Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing},
  journal = {Journal of Personalized Medicine},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {366},
  doi = {10.3390/jpm14040366}
}
Kostenlos starten →